期刊文献+

细节护理对非小细胞肺癌所致药物性皮疹的护理体会 被引量:5

Nursing Experience of Detailed nursingon Drug Rash Induced by Non-small Cell Lung Cancer
暂未订购
导出
摘要 目的探讨对非小细胞肺癌患者所致药物皮疹应用细节护理的临床效果。方法取2015年3月—2016年3月我院肿瘤科收治的分子靶向药物所致的药物性皮疹患者60例,随机分为对照组30例,采用常规护理方法,试验组30例,在对照组的基础上采用细节护理方法,观察两组患者的皮疹严重程度和感染发生率。结果试验组优于对照组,有统计学差异(P<0.05)。结论对分子靶向药物所致的药物性皮疹患者应用细节护理,可以减轻患者皮疹反应,降低患者感染率,值得推广应用。 Objective To investigate the clinical effect of the application of detailed nursing for patients with drug rash induced by non-small cell lung cancer. Methods From March 2015 to March 2016,the molecular target of our hospital admitted to drug induced drug rash patients 60 cases were randomly divided into control group of 30 cases used conventional methods of nursing and experimental group of 30 cases used detail nursing methods on the basis of the control group. The severity and infection incidence rate of skin rash in two groups were observed. Results The experimental group was better than the control group,and there was statistical difference( P〈 0. 05). Conclusion The application of detailed nursing on patients with drug rash caused by molecular targeted drugs can reduce the patient's rash reaction,and reduce the infection rate,which is worthy of popularization and application.
作者 丁瑞娟
出处 《光明中医》 2017年第8期1193-1194,共2页 GUANGMING JOURNAL OF CHINESE MEDICINE
关键词 非小细胞肺癌 靶向药物 皮疹 细节护理 Non-small cell lung cancer Targeted drugs Rash Detailed nursing
  • 相关文献

参考文献5

二级参考文献31

  • 1李进,王坤,徐崇锐,张华.Erlotinib治疗晚期非小细胞肺癌的综合研究[J].循证医学,2004,4(4):199-202. 被引量:3
  • 2梁玉梅,侯霞.腔口及皮肤护理在重症药疹患者中的应用[J].护士进修杂志,2005,20(1):49-50. 被引量:12
  • 3徐冰河 孙燕.特罗凯呵提高肺癌患者生活质量[J].肺癌论坛,2007,.
  • 4Stewart J S, Cohen E E, Licilra L, et al. Phase Ⅲ sludy of ge fitinib compared with intravenous metholrexate for recurrent squa mous cell carcinoma of the head and neckEcorrected[J]. J Clin Oncol, 2009,27: 1864- 1871.
  • 5Izzedine H, Ederhy S, Goldwasser F, et al. Management of hyper- tension in angiogenesisinhibitor treated patients[J]. Ann Oncol, 2009,20:807-815.
  • 6Llovet J M, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatoeellular carcinorna[J]. N Engl J Med,2008,359:378-390.
  • 7Chen H X, Cleck J N. Adverse effects of antfcancer agents that target the VEGF pathway[J]. Nat Rev Clin Oncol,2009,8:465-477.
  • 8Rini B I, Tamaskar I. Shaheen P, et al. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib[J]. J NatlCancer Inst,2007,99:81-83.
  • 9Chevallier P, Hunault-Berger M. Larosa F, et al. A phase II trial of high dose imatinih mesylate for relapsed or refractory c kit positive and Bcr-AbI negative acute myeloid leukaemia: the AFR 15 trial[J]. Leuk Res,2009,33:l124-1126.
  • 10Motzer R J, Escudier B, Oudard S, el al. Efficacy of everolimus in advanced renal cell carcinoma: a double- blind, randomised, place bo-controlled phase 111 tria[J]. Lancet, 2008,372:449-456.

共引文献40

同被引文献42

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部